You are here: All Products  > Avistone Biotech Approved to Launch c-Met Inhibitor for NSCLC with Mutations

Avistone Biotech Approved to Launch c-Met Inhibitor for NSCLC with Mutations

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products